← Evidence map

ReviewOncotarget2017

Bevacizumab in ovarian cancer: A critical review of phase III studies.

Luigi Rossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

66 papers cite itlatest 60 shown

2017
…
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27852039